{
    "Orphapacket": {
        "ORPHApacketId": "35889",
        "creationDate": "2025-06-26 11:48:15",
        "version": "1.3.42 / 4.1.8 [2025-03-03]",
        "copyright": "Orphanet (c) 2025",
        "ORPHAcode": "35889",
        "Label": "Acute opioid intoxication",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_35889",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A rare intoxication with opioids a large group of alkaloid analgesics mainly characterized by miosis (pinpoint pupil) respiratory depression (bradypnea/apnea) and central nervous system depression (sedation or coma). Other manifestations include hypotension reduced bowel motility hypothermia and hypoglycemia. Naloxone a competitive inhibitor of the mu-opioid receptor is a potent antagonist and is used as the antidote for opioid intoxication."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "556508",
                        "Label": "Rare disorder due to poisoning"
                    }
                ]
            }
        ],
        "Prevalences": {
            "Prevalence": [
                {
                    "Source": "ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "Unknown",
                    "ValMoy": "0.0",
                    "PrevalenceGeographic": "Worldwide"
                }
            ]
        },
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "All ages"
                }
            ]
        },
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Not applicable"
                }
            ]
        }
    }
}